KRRO vs LBRX

Korro Bio, Inc. vs LB Pharmaceuticals Inc — Valuation Comparison 2026

KRRO

Pharmaceutical Preparations
Korro Bio, Inc.
Quality
5.1
out of 10
Value Trap
28
LOW
Price
$13.41
Last close
Models
9/13
Active
VS

LBRX

Pharmaceutical Preparations
LB Pharmaceuticals Inc
Quality
4.6
out of 10
Value Trap
Price
$27.97
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType KRRO Fair ValueKRRO Upside LBRX Fair ValueLBRX Upside
Bayesian DCF Intrinsic $3.85 -71.3% $11.46 -59.0%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $9.46 -29.4% $8.72 -68.8%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for KRRO vs LBRX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

KRRO vs LBRX — Which Stock Is More Undervalued?

KRRO scores higher with a 5.1/10 quality rating vs LBRX's 4.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Korro Bio, Inc. (KRRO) and LB Pharmaceuticals Inc (LBRX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

KRRO currently trades at $13.41 with a QOC of 5.1/10, while LBRX trades at $27.97 with a QOC of 4.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).